摘要:
The present invention provides N-alkyl 2-(disubstituted)alkynyladenosine-5′-uronamides and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
摘要:
A2A agonists of formula (I) is provided, wherein R1, R2, R4, R5, X, Y, Z, n, p, and q are as described herein. Also provided are compositions comprising and methods of using compounds of formula (I).
摘要:
The present invention provides compounds and pharmaceutical compositions that are substituted xanthines of formula I: or pharmaceutically acceptable salts thereof, wherein: Z is selected from the group consisting of oxazoyl, isoxazoyl, thiazolyl, and isothiazoyl; and Z1 is a 5-14 member substituted or unsubstituted heteroaryl ring; which are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
摘要:
The present invention provides substituted 8-[6-amino-3-pyridyl]xanthines like the compound shown in the following formula: and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
摘要:
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
摘要:
Selective antagonists of A2B adenosine receptors like those of formula I are provided. These compounds and compositions are useful as pharmaceutical agents.
摘要:
The present invention provides compounds of the following formula and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
摘要:
Selective antagonists of A2A adenosine receptors like those of formula I are provided, wherein Y forms a ring. The novel A2A Blockers are useful for the treatment of Parkinson's disease and other diseases.
摘要:
An embodiment of USB device comprises a lookup table in a fixed electronically readable medium comprising a plurality of product identification information entries. The USB device also has an electronically readable index that selects one of the plurality of product identification information entries, and the vendor identification information is stored in a location separate from the index.
摘要:
A closure cap system for glass chromatography columns includes a glass cylinder with unfinished shaping or work on each end, and two sealing caps. The caps have a circumference shoulder with O-rings. The O-rings having the same diameter as the diameter of the glass cylinder unfinished ends. A base and top parts, both containing openings for receiving sealing caps and the glass cylinder. Threaded rods are received by additional openings in said top and base parts. Nuts are affixed at the end of each threaded rod. The combined action of the nuts and threaded rods apply compression forces to the caps and glass cylinder for sealing in a simple and economic manner defining the system as a disposable apparatus.